Esperion Therapeutics (LTS:0IIM) 3-Year Book Growth Rate : -1.20% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Esperion Therapeutics 3-Year Book Growth Rate?

Esperion Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was $-1.57.

During the past 3 years, the average Book Value per Share Growth Rate was -1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Esperion Therapeutics was 28.00% per year. The lowest was -58.50% per year. And the median was -3.20% per year.

Competitive Comparison of Esperion Therapeutics's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Esperion Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Esperion Therapeutics's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Esperion Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Esperion Therapeutics's 3-Year Book Growth Rate falls into.

Esperion Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Esperion Therapeutics (LTS:0IIM) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Esperion Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Esperion Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Esperion Therapeutics (LTS:0IIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Esperion Therapeutics Inc (LTS:0IIM) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

ESPR:USA 0ET:Germany

Address

3891 Ranchero Drive, Suite 150, Ann Arbor, MI, USA, 48108

Website

https://www.esperion.com

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment.

Esperion Therapeutics (LTS:0IIM) Headlines

No Headlines